GloPID-R report on chikungunya, o'nyong-nyong and Mayaro virus, part 2: Epidemiological distribution of o'nyong-nyong virus.


Journal

Antiviral research
ISSN: 1872-9096
Titre abrégé: Antiviral Res
Pays: Netherlands
ID NLM: 8109699

Informations de publication

Date de publication:
12 2019
Historique:
received: 08 09 2019
accepted: 17 09 2019
pubmed: 24 9 2019
medline: 16 7 2020
entrez: 24 9 2019
Statut: ppublish

Résumé

The GloPID-R (Global Research Collaboration for Infectious Disease Preparedness) chikungunya (CHIKV), o'nyong-nyong (ONNV) and Mayaro virus (MAYV) Working Group has been established to identify gaps of knowledge about the natural history, epidemiology and medical management of infection by these viruses, and to provide adapted recommendations for future investigations. Here, we present a report dedicated to ONNV epidemiological distribution. Two large-scale ONNV outbreaks have been identified in Africa in the last 60 years, interspersed with sporadic serosurveys and case reports of returning travelers. The assessment of the real scale of ONNV circulation in Africa remains a difficult task and surveillance studies are necessary to fill this gap. The identification of ONNV etiology is made complicated by the absence of multiplex tools in co-circulation areas and that of reference standards, as well as the high cross-reactivity with related pathogens observed in serological tests, in particular with CHIKV. This is a specific obstacle for seroprevalence studies, that necessitate an improvement of serological tools to provide robust results. The scarcity of existent genetic data currently limits molecular epidemiology studies. ONNV epidemiology would also benefit from reinforced entomological and environmental surveillance. Finally, the natural history of the disease deserves to be further investigated, with a specific attention paid to long-term complications. Considering our incomplete knowledge on ONNV distribution, GloPID-R CHIKV, ONNV and MAYV experts recommend that a major effort should be done to fill existing gaps.

Identifiants

pubmed: 31545982
pii: S0166-3542(19)30512-1
doi: 10.1016/j.antiviral.2019.104611
pii:
doi:

Substances chimiques

Iron E1UOL152H7

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

104611

Investigateurs

S Boyer (S)
P Brasil (P)
M Busch (M)
M S Diamond (MS)
M A Drebot (MA)
A Kohl (A)
M Lecuit (M)
R Lourenço-de-Oliveira (R)
J Neyts (J)
Ng Lfp (N)
G S Ribeiro (GS)
M Rios (M)
A J Rodriguez-Morales (AJ)
M G Rosa-Freitas (MG)
G Simmons (G)
A M Siqueira (AM)
A Vega Rua (A)

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.

Auteurs

L Pezzi (L)

Unité des Virus Émergents (UVE: Aix-Marseille Univ-IRD 190-Inserm 1207-IHU Méditerranée Infection), Marseille, France; EA7310, Laboratoire de Virologie, Université de Corse-Inserm, Corte, France. Electronic address: laura.pezzi3@studio.unibo.it.

A D LaBeaud (AD)

Department of Pediatrics, Division of Infectious Diseases, Stanford University School of Medicine, Stanford, USA.

C B Reusken (CB)

Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; Department Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands.

J F Drexler (JF)

Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, And Berlin Institute of Health, Institute of Virology, 10117, Berlin, Germany; German Centre for Infection Research (DZIF), Germany.

N Vasilakis (N)

Department of Pathology, Institute of Human Infection and Immunity, University of Texas Medical Branch, Galveston, USA.

M Diallo (M)

Unité D'Entomologie Médicale, Institut Pasteur de Dakar, Dakar, Senegal.

F Simon (F)

Laveran Military Teaching Hospital, Marseille, France.

T Jaenisch (T)

Section Clinical Tropical Medicine, Department of Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany.

P Gallian (P)

Établissement Français Du Sang Alpes Méditerranée, Marseille, France.

A Sall (A)

Unité D'Entomologie Médicale, Institut Pasteur de Dakar, Dakar, Senegal.

A B Failloux (AB)

Department of Virology, Institut Pasteur, Arboviruses and Insect Vectors Unit, Paris, France.

S C Weaver (SC)

Institute for Human Infections and Immunity and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, USA.

X de Lamballerie (X)

Unité des Virus Émergents (UVE: Aix-Marseille Univ-IRD 190-Inserm 1207-IHU Méditerranée Infection), Marseille, France.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH